Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
– New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review –
– New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review –
Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!